Market Cap | 74.11B | P/E | 13.57 | EPS this Y | 21.20% | Ern Qtrly Grth | 22.50% |
Income | 5.74B | Forward P/E | 13.29 | EPS next Y | 9.60% | 50D Avg Chg | -5.00% |
Sales | 68.35B | PEG | 1.57 | EPS past 5Y | 21.53% | 200D Avg Chg | 4.00% |
Dividend | 1.00% | Price/Book | N/A | EPS next 5Y | 11.43% | 52W High Chg | -12.00% |
Recommedations | 1.90 | Quick Ratio | 0.78 | Shares Outstanding | 258.07M | 52W Low Chg | 51.00% |
Insider Own | 27.88% | ROA | 11.47% | Shares Float | 185.26M | Beta | 1.68 |
Inst Own | 64.46% | ROE | 736.11% | Shares Shorted/Prior | 3.80M/2.66M | Price | 269.39 |
Gross Margin | 40.27% | Profit Margin | 8.40% | Avg. Volume | 1,323,701 | Target Price | 400.45 |
Oper. Margin | 15.61% | Earnings Date | Oct 25 | Volume | 1,168,218 | Change | -1.64% |
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
RUTHERFORD BILL B | CFO and EVP CFO and EVP | Feb 02 | Sell | 310.63 | 6,000 | 1,863,780 | 8,448 | 02/06/24 |
RUTHERFORD BILL B | CFO and EVP CFO and EVP | Feb 02 | Option | 69.58 | 19,100 | 1,328,978 | 25,469 | 02/06/24 |
Mosier Sammie S | SVP & Chief Nurse Ex.. SVP & Chief Nurse Executive | Feb 02 | Sell | 312 | 1,645 | 513,240 | 7,646 | 02/06/24 |
Mosier Sammie S | SVP & Chief Nurse Ex.. SVP & Chief Nurse Executive | Feb 02 | Option | 226.21 | 6,298 | 1,424,671 | 14,315 | 02/06/24 |
Wasserman Chad J | SVP and CIO SVP and CIO | Feb 02 | Sell | 312.04 | 652 | 203,450 | 290 | 02/06/24 |
Wyatt Christopher F. | SVP & Controller SVP & Controller | Jan 31 | Option | 91.56 | 11,680 | 1,069,421 | 47,759 | 02/02/24 |
Torres Kathryn A. | SVP-Payer Contractin.. SVP-Payer Contracting & Align. | Jan 31 | Sell | 307 | 3,861 | 1,185,327 | 15,899 | 02/02/24 |
Torres Kathryn A. | SVP-Payer Contractin.. SVP-Payer Contracting & Align. | Jan 31 | Option | 202.07 | 12,994 | 2,625,698 | 28,893 | 02/02/24 |
Cuffe Michael S. | EVP and Chief Clinic.. EVP and Chief Clinical Officer | Jan 31 | Sell | 306.79 | 3,200 | 981,728 | 24,929 | 02/02/24 |
Akdamar Erol R | Group President Group President | Nov 13 | Option | 47.97 | 26,825 | 1,286,795 | 26,825 | 11/15/23 |
Torres Kathryn A. | SVP-Payer Contractin.. SVP-Payer Contracting & Align. | Aug 14 | Sell | 269.1229 | 5,204 | 1,400,516 | 19,760 | 08/16/23 |
Cohen Jeffrey E. | SVP-Government Relat.. SVP-Government Relations | Aug 11 | Sell | 270.00 | 1,500 | 405,000 | 4,414 | 08/15/23 |
Torres Kathryn A. | SVP-Payer Contractin.. SVP-Payer Contracting & Align. | Apr 28 | Option | 142.15 | 8,844 | 1,257,175 | 31,087 | 05/02/23 |
Cuffe Michael S. | EVP and Chief Clinic.. EVP and Chief Clinical Officer | Apr 28 | Sell | 284.4374 | 12,556 | 3,571,396 | 28,783 | 05/02/23 |
Akdamar Erol R | Group President Group President | Apr 28 | Sell | 285 | 3,500 | 997,500 | 42,484 | 05/02/23 |
Paslick P. Martin | SVP and CIO SVP and CIO | Apr 12 | Sell | 275 | 2,687 | 738,925 | 24,643 | 04/14/23 |
Paslick P. Martin | SVP and CIO SVP and CIO | Apr 12 | Option | 81.96 | 6,340 | 519,626 | 30,983 | 04/14/23 |
Paslick P. Martin | SVP and CIO SVP and CIO | Apr 10 | Sell | 270.00 | 2,539 | 685,530 | 24,643 | 04/12/23 |
Paslick P. Martin | SVP and CIO SVP and CIO | Apr 04 | Sell | 265 | 3,034 | 804,010 | 24,643 | 04/06/23 |
Paslick P. Martin | SVP and CIO SVP and CIO | Apr 04 | Option | 81.96 | 6,000 | 491,760 | 30,643 | 04/06/23 |
Whalen Kathleen M | SVP & Chief Ethics O.. SVP & Chief Ethics Officer | Feb 17 | Sell | 263.61 | 1,734 | 457,100 | 9,962 | 02/22/23 |
Torres Kathryn A. | SVP-Payer Contractin.. SVP-Payer Contracting & Align. | Feb 16 | Option | 101.16 | 4,575 | 462,807 | 24,947 | 02/21/23 |
Berres Jennifer | SVP & Chief Human Re.. SVP & Chief Human Res. Officer | Feb 07 | Sell | 255.228 | 4,000 | 1,020,912 | 7,392 | 02/09/23 |
Reiner Deborah M | SVP - Mktg. & Commun.. SVP - Mktg. & Communications | Feb 03 | Sell | 257.6123 | 7,941 | 2,045,699 | 02/07/23 | |
HAZEN SAMUEL N | CEO CEO | Feb 03 | Option | 68.96 | 59,000 | 4,068,640 | 137,885 | 02/07/23 |
Akdamar Erol R | Group President Group President | Feb 02 | Sell | 258.63 | 3,000 | 775,890 | 34,726 | 02/06/23 |
Akdamar Erol R | Group President Group President | Feb 02 | Option | 45.3 | 9,000 | 407,700 | 43,726 | 02/06/23 |
RUTHERFORD BILL B | CFO and EVP CFO and EVP | Feb 01 | Sell | 258.19 | 30,000 | 7,745,700 | 81,632 | 02/03/23 |
RUTHERFORD BILL B | CFO and EVP CFO and EVP | Feb 01 | Option | 69.27 | 64,000 | 4,433,280 | 146,527 | 02/03/23 |
Wyatt Christopher F. | SVP & Controller SVP & Controller | Jan 30 | Sell | 253.3 | 4,900 | 1,241,170 | 32,392 | 02/01/23 |
Wyatt Christopher F. | SVP & Controller SVP & Controller | Jan 30 | Option | 81.96 | 12,000 | 983,520 | 44,184 | 02/01/23 |
Whalen Kathleen M | SVP & Chief Ethics O.. SVP & Chief Ethics Officer | Jan 30 | Option | 69.58 | 1,250 | 86,975 | 12,282 | 02/01/23 |
Paslick P. Martin | SVP and CIO SVP and CIO | Jan 30 | Sell | 256.9487 | 1,000 | 256,949 | 3,000 | 02/01/23 |
McManus Timothy M | Group President Group President | Jan 30 | Sell | 254.33 | 7,900 | 2,009,207 | 13,987 | 02/01/23 |
Foster Jon M | EVP and COO EVP and COO | Jan 30 | Sell | 251.98 | 16,424 | 4,138,520 | 10,938 | 02/01/23 |
Foster Jon M | EVP and COO EVP and COO | Jan 30 | Option | 69.27 | 35,955 | 2,490,603 | 46,893 | 02/01/23 |
Cuffe Michael S. | EVP and Chief Clinic.. EVP and Chief Clinical Officer | Jan 30 | Sell | 257.11 | 4,000 | 1,028,440 | 20,823 | 02/01/23 |
Paslick P. Martin | SVP and CIO SVP and CIO | Jan 23 | Option | 81.96 | 6,000 | 491,760 | 25,112 | 01/25/23 |
MOORE A BRUCE JR | Group President - Se.. Group President - Service Line | Oct 27 | Option | 37.18 | 35,625 | 1,324,538 | 58,516 | 10/31/22 |
Billington Phillip G | SVP-Internal Audit S.. SVP-Internal Audit Services | Oct 26 | Option | 37.18 | 16,575 | 616,258 | 57,227 | 10/28/22 |
Billington Phillip G | SVP-Internal Audit S.. SVP-Internal Audit Services | Oct 26 | Sell | 222.58 | 8,332 | 1,854,537 | 40,652 | 10/28/22 |
Sowell Joseph A III | SVP; Chief Developme.. SVP; Chief Development Officer | Oct 25 | Option | 47.97 | 27,500 | 1,319,175 | 27,500 | 10/27/22 |
Elcan Patricia F | 10% Owner 10% Owner | Jul 25 | Buy | 198.66 | 325 | 64,564 | 89,337 | 07/27/22 |
Berres Jennifer | SVP & Chief Human Re.. SVP & Chief Human Res. Officer | May 13 | Sell | 218.8662 | 2,358 | 516,086 | 11,392 | 05/17/22 |
Whalen Kathleen M | SVP & Chief Ethics O.. SVP & Chief Ethics Officer | May 03 | Sell | 215.38 | 500 | 107,690 | 11,373 | 05/05/22 |
FRIST THOMAS F JR | 10% Owner 10% Owner | May 02 | Buy | 212.48 | 89,100 | 18,931,968 | 478,955 | 05/04/22 |
McAlevey Michael R | SVP & Chief Legal Of.. SVP & Chief Legal Officer | Apr 29 | Buy | 218.5604 | 1,110 | 242,602 | 1,110 | 05/03/22 |
Smith Andrea B | Director Director | Apr 28 | Buy | 213.6339 | 1,160 | 247,815 | 2,239 | 05/02/22 |
Sowell Joseph A III | SVP; Chief Developme.. SVP; Chief Development Officer | Mar 11 | Sell | 269.00 | 11,522 | 3,099,418 | 17,051 | 03/15/22 |
MOORE A BRUCE JR | Group President - Se.. Group President - Service Line | Feb 16 | Sell | 248.59 | 30,000 | 7,457,700 | 91,788 | 02/18/22 |